We serve Chemical Name:LY341495 CAS:201943-63-7 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:LY341495
CAS.NO:201943-63-7
Synonyms:(1S,2S)-2-[(1S)-1-Amino-1-carboxy-2-(9H-xanthen-9-yl)ethyl]cyclopropanecarboxylic acid;9H-Xanthene-9-propanoic acid, α-amino-α-[(1S,2S)-2-carboxycyclopropyl]-, (αS)-;cc-481;HMS3267B15;LY-341,495;Z99;LY341495
Molecular Formula:C20H19NO5
Molecular Weight:353.369
HS Code:
Physical and Chemical Properties:
Melting point:N/A
Boiling point:580.8±40.0 °C at 760 mmHg
Density:1.4±0.1 g/cm3
Index of Refraction:1.669
PSA:109.85000
Exact Mass:353.126312
LogP:2.53
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like (1S,2S)-2-[(1S)-1-Amino-1-carboxy-2-(9H-xanthen-9-yl)ethyl]cyclopropanecarboxylic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,LY341495 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,LY341495 Use and application,LY-341,495 technical grade,usp/ep/jp grade.
Related News: At the same time, due to the relatively late development of the bulk drug business in China, most of the established bulk drug companies are currently in the field of commonly used generic drug bulk drugs. Stand up. LY341495 manufacturer The national airlines of Egypt, Qatar and Saudi Arabia have halted flights to and from China. LY341495 supplier At the same time, due to the relatively late development of the bulk drug business in China, most of the established bulk drug companies are currently in the field of commonly used generic drug bulk drugs. Stand up. LY341495 vendor Villages and cities in China have resorted to flying drones with speakers to patrol streets and scold people not wearing masks in public amid the coronavirus outbreak, according to Chinese state media. LY341495 factory The company��s proprietary induced pluripotent stem cell (iPSC) product platform enables mass production of off-the-shelf, engineered, homogeneous cell products that can be administered with multiple doses to deliver more effective pharmacologic activity, including in combination with cycles of other cancer treatments.
